IP Library Granted Patent US 12,428,651
Granted Patent B2
US 12,428,651 · App. 18/309,524 · Granted Sep 30, 2025

Transcription factors to improve resistance to environmental stress in plants

Inventors: Gregg A. Howe (East Lansing, MI); Marcelo Campos (Lago Norte, BR); Yuki Yoshida (Tokyo, JP)
Assignee: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
C12N15/8286
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,428,651
App. No.
18/309,524
Granted
Sep 30, 2025
Kind
B2
Abstract

Plants, plant cells, and seeds are described herein that grow well and are resistant to environmental stresses such as drought and insects, where the plants have one or more mutations that reduce or eliminate the interaction of MYC transcription factors with the JAZ proteins. The plants can have an additional mutation that reduces or eliminates the function of the PHYB gene, and/or a heterologous PIF4 transgene or PIF4 expression cassette to improve the growth of the myc mutant plants. Methods of making and using such plants, plant cells, and seeds are also described.

Claims (19)

1. A genetically modified and non-naturally occurring mutant plant cell, a mutant plant, or a mutant plant seed obtained thereof, comprising:

(a) a PhyB loss-of-function mutation comprising at least one mutation to an amino acid in the amino acid sequence as set forth in SEQ ID NO: 33; and

(b) a modified MYC nucleic acid encoding a mutant MYC protein comprising at least one mutation within a JAZ-interacting domain (JID) region of the mutant MYC protein that reduces or eliminates interaction of the mutant MYC protein with JAZ proteins, wherein the JAZ interacting domain (JID) has less than 100% and more than 95% amino acid sequence identity to the amino acid sequence as set forth in SEQ ID NO: 10, and wherein the mutant MYC protein has less than 100% amino acid sequence identity and at least 95% amino acid sequence identity to the amino acid sequence as set forth in SEQ ID NO: 9, and

wherein the genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof is a transgenic mutant, and wherein expression or lack of expression of the PhyB loss-of-function mutant protein, and expression of the MYC mutant protein rescues wild-type plant biomass and concurrently provides JA (jasmonic acid)-controlled defense in the genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof as compared to a control plant of the same species that is grown under the same conditions, and wherein said JA-controlled defense is resistance to an environmental stress.

2. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , wherein the PhyB loss-of-function mutation comprises a deletion, substitution, or insertion of a wild-type chromosomal PhyB gene encoding the PhyB polypeptide of SEQ ID NO: 33 so that a truncated PHYB polypeptide, a mutant PHYB polypeptide, or no PHYB polypeptide is expressed.

3. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , wherein the mutant MYC protein has reduced binding to a JAZ protein from Zea mays as set forth in SEQ ID NO: 60, and wherein the binding is reduced by at least 20% as compared to a corresponding wild type MYC protein that does not have said at least one MYC mutation.

4. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , wherein the modified MYC nucleic acid is a modification by having a deletion, substitution, or insertion of a chromosomal wild-type MYC gene encoding the protein of SEQ ID NO: 9 to encode the mutant MYC protein.

5. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , comprising one or more deletions, substitutions, or insertions into one or five wild-type genomic JAZ nucleic acids that encode JAZ proteins with at least 95% amino acid sequence identity to the amino acid sequences as set forth in SEQ ID NO: 60.

6. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , comprising a loss-of-function chromosomal mutation in an endogenous Zea mays JAZ gene encoding the JAZ protein as set forth in SEQ ID NO: 60.

7. The genetically modified and non-naturally occurring mutant plant cell, the mutant plant, or the mutant plant seed obtained thereof, of claim 1 , wherein the mutant plant or a mutant plant grown from the seed exhibits resistance to the environmental stress compared to a wild type plant of the same species grown under the same environmental conditions, and wherein the environmental stress is insect stress or oxidative stress.

8. A method comprising:

(a) providing one or more genetically modified and non-naturally occurring mutant plant cells comprising a PhyB loss-of-function mutation comprising at least one mutation to an amino acid in the amino acid sequence as set forth in SEQ ID NO: 33;

(b) introducing into at least one of the mutant plant cells at least one transgene or expression cassette encoding a mutant MYC nucleic acid segment that encodes a mutant MYC protein to generate one or more transformed plant cell(s), wherein the mutant MYC protein has less than 100% amino acid sequence identity and at least 95% amino acid sequence identity to the amino acid sequence as set forth in SEQ ID NO: 9, and wherein the mutant MYC protein comprises at least one mutation within a JAZ-interacting domain (JID) region that reduces or eliminates interaction of the mutant MYC protein with JAZ proteins, wherein the JAZ interacting domain (JID) has less than 100% and more than 95% amino acid sequence identity to the amino acid sequence as set forth in SEQ ID NO: 10; and

(c) generating a genetically modified and non-naturally occurring mutant plant from the one or more transformed plant cells,

wherein expression or lack of expression of the PhyB loss-of-function mutant protein, and expression of the MYC mutant protein rescues wild-type plant biomass and concurrently provides JA (jasmonic acid)-controlled defense in the genetically modified and non-naturally occurring mutant plant as compared to a control plant of the same species that is grown under the same conditions, and wherein said JA-controlled defense is resistance to an environmental stress.

9. The method of claim 8 , further comprising introducing into said at least one of the transformed plant cells one or more deletions, substitutions, or insertions into one or five wild-type genomic JAZ nucleic acids that encode JAZ proteins with at least 95% amino acid sequence identity to the amino acid sequences as set forth in SEQ ID NO: 60.

10. The method of claim 8 , wherein the mutant MYC nucleic acid segment that encodes the mutant MYC protein is a dominant MYC mutation.

11. The method of claim 8 , wherein the mutant MYC protein has reduced binding to a JAZ protein from Zea mays as set forth in SEQ ID NO: 60, and wherein the binding is reduced by at least 20% as compared to a corresponding wild type MYC protein that does not have said at least one MYC mutation.

12. The method of claim 8 , wherein the genetically modified and non-naturally occurring mutant plant exhibits resistance to the environmental stress as compared to a wild type plant of the same species grown under the same environmental conditions, and wherein the environmental stress is insect stress or oxidative stress.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2025
From: HOWE, GREGG A.; CAMPOS, MARCELO; YOSHIDA, YUKI
To: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
Reel/Frame 071732/0122 →
Continuity (3)
Continuation 16323737
Provisional Application 62379773 · Aug 26, 2016
Related Publication 20230365987A1 · Nov 16, 2023
References Cited (68)
US 8735555B2 · Lagarias et al. · 2014 [cited by applicant]
US 11674151B2 · Howe et al. · 2023 [cited by applicant]
US 20140246036A1 · Qu et al. · 2014 [cited by applicant]
US 20190330653A1 · Howe et al. · 2019 [cited by applicant]
CN 101899449A · 2010 [cited by applicant]
CN 103602686A · 2014 [cited by applicant]
EP 3504334B1 · 2023 [cited by applicant]
WO WO2015124620A1 · 2015 [cited by applicant]
WO WO2018039590A1 · 2018 [cited by applicant]
Leone et al. (New Phytologist, 204:355-367, 2014). [cited by examiner]
Niu et al. (J Exp bot., 62:2143-2154, 2011). [cited by examiner]
Loulergue et al. (Gene, 225:47-57, 1998). [cited by examiner]
Alexandrov et al. (NCBI, GenBank sequence Accession No. NP_001308779, Published Apr. 1, 2016). [cited by examiner]
Reed et al. (Plant Cell, 5:147-157, 1993). [cited by examiner]
Sheehan et al. (NCBI, GenBank Sequence Accession No. Q6XFQ3, Published Nov. 28, 2006). [cited by examiner]
Doerks et al., (TIG, 14:248-250, 1998). [cited by examiner]
Smith et al. (Nature Biotechnology, 15:1222-1223, 1997). [cited by examiner]
Bork et al. (TIG, 12:425-427, 1996). [cited by examiner]
“Canadian Application Serial No. 3,035,084, Response filed Dec. 1, 2023 to Examiners Rule 86(2) Requisition mailed Aug. 1, 2023”. [cited by applicant]
“Brazilian Application Serial No. BR1120190038884, Response filed Mar. 23, 2023 to Office Action mailed Dec. 14, 2022”, with English claims, 17 pages. [cited by applicant]
“Canadian Application Serial No. 3,035,084, Examiners Rule 86(2) Requisition mailed Aug. 1, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Non Final Office Action mailed Jun. 9, 2022”, 20 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Notice of Allowance mailed Jan. 30, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Preliminary Amendment Filed Feb. 6, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Response filed Mar. 7, 2022 to Restriction Requirement mailed Jan. 6, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Response filed Oct. 10, 2022 to Non Final Office Action mailed Jun. 9, 2022”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 16/323,737, Restriction Requirement mailed Jan. 6, 2022”, 6 pgs. [cited by applicant]
“Brazilian Application Serial No. BR1120190038884, Office Action mailed Dec. 14, 2022”, w/ English Translation, 7 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Communication Pursuant to Article 94(3) EPC mailed Apr. 6, 2020”, 5 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Communication Pursuant to Article 94(3) EPC mailed Jul. 22, 2022”, 4 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Communication Pursuant to Article 94(3) EPC mailed Aug. 25, 2021”, 4 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Communication Pursuant to Article 94(3) EPC mailed Nov. 26, 2020”, 4 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Response filed Apr. 13, 2021 to Communication Pursuant to Article 94(3) EPC mailed Nov. 26, 2020”, 12 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Response filed Aug. 13, 2020 to Communication Pursuant to Article 94(3) EPC mailed Apr. 6, 2020”, 9 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Response Filed Dec. 6, 2022 to Communication Pursuant to Article 94(3) EPC mailed Jul. 22, 2022”, 168 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Response filed Dec. 31, 2021 to Communication Pursuant to Article 94(3) EPC mailed Aug. 25, 2021”, 12 pgs. [cited by applicant]
“European Application Serial No. 17761766.9, Response to Response to Communication pursuant to Rules 161(1) and 162 EPC filed Oct. 22, 2019”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048660, International Preliminary Report on Patentability mailed Mar. 7, 2019”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048660, International Search Report mailed Oct. 18, 2017”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2017/048660, Written Opinion mailed Oct. 18, 2017”, 5 pgs. [cited by applicant]
Boccalandro, H. E., et al., “Phytochrome B Enhances Photosynthesis at the Expense of Water-Use Efficiency in [cited by applicant]
Bork, Peer, “Go hunting in sequence databases but watch out for the traps”, Trends in Genetics, 12(10), (Oct. 1996), 425-427. [cited by applicant]
Boter, M., et al., “Conserved MYC transcription factors play a key role in jasmonate signaling both in tomato and [cited by applicant]
Campos, M. L., et al., “Rewiring of jasmonate and phytochrome B signalling uncouples plant growth-defense tradeoffs”, Nature Communications, 7: Article No. 12570, (2016), 1-10. [cited by applicant]
Chico, Jose Manuel, et al., “Repression of Jasmonate-Dependent Defenses by Shade Involves Differential Regulation of Protein Stability of MYC Transcription Factors and Their JAZ Repressors in [cited by applicant]
Chung, H. S., et al., “A Critical Role for the TIFY Motif in Repression of Jasmonate Signaling by a Stabilized Splice Variant of the JASMONATE ZIM-Domain Protein JAZ10 in [cited by applicant]
Doerks, Tobias, et al., “Protein Annotation: detective work for function prediction”, Trends in Genetics, vol. 14, No. 6, (1998), 248-250. [cited by applicant]
Fernandez-Calvo, P., et al., “The [cited by applicant]
Frances, Robson, et al., “Jasmonate and Phytochrome Signaling in Arabidopsis Wound and Shade Responses Are Integrated through JAZ1 Stability”, The Plant Cell, (Apr. 1, 2010), 1143-1160. [cited by applicant]
Gasperini, D., et al., “Multilayered Organization of Jasmonate Signalling in the Regulation of Root Growth”, PoOS Genetics, 11(6): e1005300., (2015), 27 pgs. [cited by applicant]
Goosens, J., et al., “Change of a conserved amino acid in the MYC2 and MYC3 transcription factors leads to release of JAZ repression and increased activity”, New Phytoologist, 206, (2015), 1229-1237. [cited by applicant]
Hoo, Sun Chung, et al., “Top hits in contemporary JAZ: An update on jasmonate signaling”, Phytochemistry, (Sep. 1, 2009), vol. 70, No. 13-14, (Sep. 1, 2009), 24 pgs. [cited by applicant]
Hoo, Sun Chung, et al., “Top hits on contemporary JAZ An update on jasmonate signaling”, (Sep. 1, 2009), 1547-1559. [cited by applicant]
Hornitschek, P., et al., “Phytochrome interacting factors 4 and 5 control seedling growth in changing light conditions by directly controlling auxin signaling”, Plant J., 71, (2012), 699-711. [cited by applicant]
I, Cerrudo, et al., “Low Red/Far-Red Ratios Reduce [cited by applicant]
J, M Chico, et al., “Repression of Jasmonate-Dependent Defenses by Shade Involves Differential Regulation of Protein Stability of MYC Transcription Factors and Their JAZ Repressors in [cited by applicant]
Kazan, K., et al., “MYC2: The Master in Action”, Molecular Plant 6(3), (2013), 686-703. [cited by applicant]
Leone, Melisa, et al., “To grow or defend? Low red far-red ratios reduce jasmonate sensitivity in [cited by applicant]
Lorenzo, O., et al., “JASMONATE-INSENSISTIVE1 Encodes a MYC Transcription Factor Essential to Discriminate between Differnt Jasmonate-Regulated Defense Responses in [cited by applicant]
Major, I. T., “Regulation of growth-defense balance by the Jasmonate Zim-Domain (Jaz)-Myc transcriptional module”, The New Phytologist, 215(4), (2017), 1533-1547. [cited by applicant]
Marcelo, Campos, et al., “Rewiring of jasmonate and phytochrome signalling uncouples plant growth-defense tradeoffs”, Nature Communications, (Aug. 30, 2016). [cited by applicant]
Melisa, Leone, et al., “”, New Phytologist; 204, (2014), 355-367. [cited by applicant]
Moreno, J. E., et al., “Ecological modulation of plant defense via phytochrome control of jasmonate sensitivity”, Proc Natl Acad Sci U S A 106, (2009), 4935-4940. [cited by applicant]
Reed, J. W., et al., “Mutations in the gene for the red/far-red light receptor phytochrome B alter cell elongation and physiological responses throughout [cited by applicant]
Smith, Temple F, et al., The Challenges of Genome Sequence Annotation or “The Devil is in the Details”, Nature Biotechnology, 15(12), (Nov. 1997), 1222-1223. [cited by applicant]
Smolen, G. A., et al., “Dominant Alleles of the Basic Helix-Loop-Helix Transcription Factor ATR2 Activate Stress-Responsive Genes in [cited by applicant]
Yang, D. L., et al., “Plant hormone jasmonate prioritizes defense over growth by interfering with gibberellin signaling cascade”, Proc. Natl. Acad. Sci. USA, 109(19), (2012), E1192- E1200. [cited by applicant]
Zhang, F., et al., “Structural basis of JAZ repression of MYC transcription factors in jasmonate signaling”, Nature, 525(7568), (2015), 269-273 (17 pgs.). [cited by applicant]